Related Experiment Video
Updated: Sep 14, 2025

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
COVID-19 with acute myocardial infarction evaluated using multimodal imaging: A case report
Jingyao Wang1, Yachao Li1, Mengjie Lei1
1Department of Cardiology, Langfang People's Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of CAD, Langfang, China.
Insights
Coronavirus disease 2019 (COVID-19) may trigger acute myocardial infarction by causing inflammation and hypercoagulability, destabilizing coronary plaques. Monitoring inflammatory markers is crucial for patients with COVID-19 and cardiovascular risks.
Area of Science:
- Cardiology
- Infectious Diseases
- Vascular Biology
Background:
- Cardiovascular complications, including acute myocardial infarction, persist as a concern despite the diminished global impact of coronavirus disease 2019 (COVID-19).
- COVID-19 may destabilize pre-existing coronary plaques via systemic inflammation and hypercoagulability.
Purpose of the Study:
- To investigate the potential role of COVID-19 in acute myocardial infarction development.
- To offer insights into diagnostic and therapeutic strategies for patients experiencing cardiovascular events post-COVID-19.
Main Methods:
- A case study of a 41-year-old woman with no prior cardiovascular risk factors presenting with chest pain 5 days after COVID-19 diagnosis.
- Diagnostic procedures included electrocardiography, troponin I measurement, emergency coronary angiography, and optical coherence tomography.
- Interventions involved thrombus aspiration, optical coherence tomography-guided angioplasty, and initiation of lipid-lowering and dual antiplatelet therapies.
Main Results:
- Coronary angiography revealed acute anterior myocardial infarction due to 90% stenosis and thrombus in the left anterior descending artery.
- Optical coherence tomography identified vulnerable, non-ruptured plaques with macrophages and cholesterol crystals.
- Post-procedural imaging indicated residual plaque burden and myocardial injury, suggesting dual ischemic and inflammatory processes.
Conclusions:
- COVID-19 may induce acute myocardial infarction by promoting atherosclerotic plaque destabilization through inflammation and hypercoagulability.
- Monitoring inflammatory markers and considering anti-inflammatory treatments are essential for managing such patients.
Rationale:
Although the global impact of coronavirus disease 2019 (COVID-19) has diminished, cardiovascular complications, such as acute myocardial infarction, remain a critical concern. This case highlights the potential role of COVID-19 in destabilizing preexisting coronary plaques through systemic inflammation and hypercoagulability, offering insights into diagnostic and therapeutic strategies for similar patients.
Patient Concerns:
A 41-year-old woman with no prior cardiovascular risk factors presented with sudden-onset chest pain 5 days after a confirmed COVID-19 diagnosis. Initial electrocardiography showed ST-segment changes and troponin I levels were mildly elevated.
Diagnosis:
Emergency coronary angiography revealed 90% stenosis in the middle segment of left anterior descending artery with thrombus, confirming acute anterior myocardial infarction. Optical coherence tomography identified vulnerable plaque features, including macrophages and cholesterol crystals, without plaque rupture.
Interventions And Outcomes:
Thrombus aspiration and optical coherence tomography-guided drug-eluted balloon angioplasty were performed. Post-procedural multimodal imaging (coronary computed tomography angiogram, cardiac magnetic resonance) demonstrated residual plaque burden and mid-myocardial late gadolinium enhancement, suggesting dual ischemic and inflammatory injuries. Intensive lipid-lowering therapy (alirocumab and rosuvastatin) and dual antiplatelet therapy were also administered.
Lessons:
The disease course of the patient suggests that COVID-19 could play a role in the destabilization of atherosclerotic plaques through a high inflammatory status in the blood vessels, leading to a hypercoagulable state and acute myocardial infarction induction. Therefore, monitoring inflammatory markers and administering adequate anti-inflammatory treatments may be necessary for such patients.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Imaging Studies for Cardiovascular System V: CT
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome IV: Interprofessional Care

